Trial Profile
An Open Label Study Of Zonegran (Zonisamide) In Patients With Partial Onset Seizures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2019
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 11 May 2008 End date, status and patient no's updated from nct (7-5-08) via dms.
- 11 May 2008 Status changed from in progress to completed.
- 07 Aug 2007 Status changed from recruiting to in progress.